Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

Older age at diagnosis was strongly associated with chemotherapy dose reductions in this population-based cohort, particularly at chemotherapy initiation but also across the course of treatment.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-10-28
DOI
https://doi.org/10.1093/jnci/djaf314
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

Elisa V. Bandera, Emily Valice, Jenna Bhimani, Kanichi G. Nakata et al.
JNCI Journal of the National Cancer Institute
Breast Cancer Treatment Studies
article

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

Elisa V. Bandera, Emily Valice, Jenna Bhimani, Kanichi G. Nakata, Isaac Joshua Ergas, Tatjana Kolevska, Kelli O’Connell, Raymond Liu, Lawrence H. Kushi, Grace Gallagher, Sara Tabatabai, Erin J. Aiello Bowles, Sonia Persaud, Yuriy Kotsurovskyy, Janise M. Roh, Donna R. Rivera, Narre Heon, Candyce H. Kroenke, Jennifer J. Griggs, Elizabeth D. Kantor, Victoria Blinder, Cecile A. Laurent, Peng Wang, Rachael Doud
article en

Abstract

Older age at diagnosis was strongly associated with chemotherapy dose reductions in this population-based cohort, particularly at chemotherapy initiation but also across the course of treatment.

JNCI Journal of the National Cancer InstituteVol. 118(2)
Rutgers, The State University of New Jersey (US), United States Food and Drug Administration (US), Memorial Sloan Kettering Cancer Center (US), Kaiser Permanente (US), Kaiser Permanente Washington Health Research Institute (US), University of Michigan (US), Cancer Institute (WIA) (IN), Michigan Medicine (US), Kaiser Permanente Vallejo Medical Center (US), Kaiser Permanente San Francisco Medical Center (US)
Openalex Percentile: Top 61%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.